Here, we report unbiased screens for genes expressed in metastatic tumor cells that are associated with cell motility. These screens identified Ier2, an immediate early gene of unknown function, as potentially having a role in tumor cell motility and metastasis. Knockdown of Ier2 in 3T3 fibroblasts inhibited their motility upon relief of contact inhibition in monolayer wounding assays. Furthermore, ectopic Ier2 expression promoted the motility and invasiveness of poorly metastatic 1AS pancreatic tumor cells in vitro. Relief of contact inhibition was associated with translocation of the Ier2 protein from the cytoplasm to the nucleus in both 3T3 fibroblasts and 1AS tumor cells. Importantly, ectopic Ier2 expression in 1AS cells stimulated metastasis formation when cells were implanted into experimental animals. Furthermore, we found elevated Ier2 expression in a wide variety of human tumor types. This correlated with poor metastasis-free and overall survival in patients with colorectal adenocarcinomas. Together, these data reveal Ier2 as a new player in the regulation of tumor progression and metastasis, and suggest that Ier2 may be useful prognostically and therapeutically in the management of cancer.
Introduction
Tumor metastasis is a highly complex molecular and cellular process (reviewed in Sleeman et al. (2011) ). Local invasion of tumor cells involves changes in adhesive properties, activation of proteolysis and acquisition of cell motility. Thereafter, tumor cells penetrate vessels of the circulatory system and are transported to distant sites where they need additional properties to form metastatic lesions. Much remains to be discovered about the changes in gene expression required for metastasis. The identification of genes specifically expressed or suppressed in metastatic tumor cells compared with their non-metastatic counterparts will not only aid in the understanding of the molecular regulation of metastasis but will also have potential applications in the development of novel diagnostic and therapeutic tools for use in the care of cancer patients.
We have previously used suppression subtractive hybridization to identify a library of genes the expression of which correlates with the metastatic potential of tumor cells (Nestl et al., 2001) . Here, we describe the further screening of this library to identify genes that might have a role in the migration of metastasizing cells. This was achieved by looking for the differential expression of the library genes in activated and nonactivated T lymphocytes. Antigen-activated T cells share many properties with metastatic tumor cells (Herrlich et al., 1993) . We reasoned that genes commonly expressed by both activated T cells and metastatic tumor cells may be functionally relevant for tumor metastasis. One gene identified by the secondary screening of the subtractive library was Ier2, the expression of which was found to be elevated in both activated lymphocytes and in various metastatic tumor cells.
Ier2 (also called ETR101, Pip92, 3CH92 and CHX1, hereafter referred to as Ier2, regardless of species) is an immediate early gene ( Rollins and Stiles, 1989 ) that was originally found to be upregulated in fibroblasts upon their activation (Lau and Nathans, 1985) . Immediate early genes are a group of genes that are rapidly induced in quiescent cells by proliferation-and migrationinducing stimuli. Mutation or inappropriate expression of several of these genes (for example, members of the fos, jun and nuclear factor-kB gene families) has been shown to cause them to function as oncogenes and/or to contribute to tumor progression (reviewed in Aggarwal (2004) and Milde-Langosch (2005) .
Here, we show that expression of Ier2 correlates with the metastatic phenotype in a wide range of rodent and human tumor types. Ectopic expression of Ier2 in poorly metastatic pancreatic tumor cells promotes their metas-tasis in vivo and enhances their motility and invasiveness in culture. Furthermore, high expression of Ier2 in human colorectal carcinoma patients was found to be significantly associated with short metastasis-free survival and poor overall survival. Therefore, these data identify Ier2 as a metastasis-relevant immediate early gene the expression of which represents a prognostic marker and a potential target for cancer therapy.
Results
Ier2 is expressed in both activated T cells and metastatic tumor cells 1AS pancreatic carcinoma cells form primary tumors but rarely metastasize in vivo, whereas ASML cells derived from the same primary tumor as 1AS cells are highly metastatic and disseminate from subcutaneous sites through the lymphatics to colonize the lungs (Nestl et al., 2001 ). We have previously described a subtractive library that was created through suppression subtractive hybridization comparison of these two cell lines (Nestl et al., 2001) . To identify genes in this library that may have a role in invasive migration, we screened the library to identify transcripts that are upregulated in activated T cells in comparison with non-activated T cells. For this purpose, inserts of the cDNA library were PCR amplified and differentially hybridized with radiolabeled probes derived from concanavilin A-activated and nonactivated splenocytes. Nine clones from the library were found to be upregulated in concanavilin A-treated cells compared with non-treated cells (data not shown).
We further screened the nine clones to identify those that are upregulated in metastatic cells compared with non-metastatic cells in a broad panel of tumor cell lines. To this end, we performed northern blots using RNA derived from rat pancreatic, mammary and prostate tumor cell lines with verified metastatic potential in vivo. Only one of these nine clones was consistently upregulated in a metastasis-relevant manner in all cell lines tested ( Figure 1a ). Sequence analysis of this clone revealed a 128-bp insert with complete homology to the 5 0 coding sequence of Ier2. To confirm the RNA expression data at the protein level, we generated and affinity purified polyclonal antiIer2 antibodies that cross-reacted with the rat, mouse and human Ier2 protein. Western blots of lysates from tumor cell lines with defined metastatic potential in vivo were probed with these antibodies. These data confirmed that constitutive Ier2 protein expression in tumor cells correlates with metastatic potential (Figure 1b ).
Ier2 expression can promote cell motility Activation of resting lymphocytes and stimulation of quiescent fibroblasts increase their migratory activity (Herrlich et al., 1993; Bradley, 2003; Li et al., 2004) . As previously reported, we found that concanavilin Aactivated splenocytes and serum-stimulated quiescent murine 3T3 fibroblasts exhibit immediate early expression of Ier2 (Figure 1, Supplementary Figure 1a) . Therefore, we investigated whether Ier2 expression might influence cell motility, as enhanced motility is associated with metastasis.
Using the well-established 3T3 fibroblast model system for investigating cell motility, we first knocked down Ier2 expression (Supplementary Figure 1b) and examined the effect on motility after relief of contact inhibition in dense monolayers. To this end, we included a silicon insert in cell cultures during establishment of the monolayer that was subsequently removed to create a cell-free area, thereby relieving contact inhibition. Serum-starved fibroblasts filled the cell-free area more slowly than did serumstimulated cells. In both cases, knockdown of Ier2 retarded closure of the cell-free area. This retardation was most pronounced in serum-stimulated cells (Figure 2 ). Knockdown of Ier2 had no effect on cell proliferation or apoptosis (Supplementary Figure 2) , supporting the notion that Ier2 supports the motility of fibroblasts.
To examine the consequences of constitutively augmented Ier2 expression in non-transformed cells, we used the ecdysone-based Rheoswitch-inducible expression system to ectopically express Ier2 conditionally in 3T3 fibroblasts (Wallbaum et al., 2009) . In these cells, Ier2 expression is upregulated after 3 h of treatment with the Rheoswitch ligand RSL1, and can be maintained in cycling cells over several days at a level that is above the peak induction levels achieved in serum-stimulated postquiescent fibroblasts (Supplementary Figure 3) . Using this system, we observed no significant increase in cell motility upon induction of Ier2 over and above that supported by endogenous Ier2 (Figure 2c ). Therefore, these data suggest that Ier2 expression has a role in fibroblast motility, as evidenced by the knockdown data, but that above a certain threshold of Ier2 expression, no further increase in motility can be induced. Ier2 and metastasis A Neeb et al Next, we examined the subcellular distribution of Ier2 before and after relief of contact inhibition subsequent to removal of the silicon insert. In the densely growing fibroblast monolayer before relief of contact inhibition, Ier2 was cytoplasmic and largely excluded from the nucleus. Lack of incorporation of 5-bromo-2 0 -deoxyuridine into cells confirmed that contact inhibition induced quiescence. Three hours after relief of contact inhibition, the Ier2 protein translocated to the nucleus in cells on the edge of the monolayer. Nuclear translocation was even more pronounced after 6 h as cells at the edge of the monolayer delaminated and began to migrate into the cell-free area (Figure 2d ).
Ier2 expression promotes invasiveness of 1AS tumor cells
To determine whether Ier2 expression in tumor cells can also increase motility and influence invasiveness, we created an expression construct for Ier2 and used it to transiently transfect poorly metastatic 1AS tumor cells. Transient expression of Ier2 had no effect on the proliferation, apoptosis or adhesion of 1AS cells (Supplementary Figure 4 ). We then determined whether the speed of closure of scratch wounds made in monolayers of Ier2-transfected 1AS cells was different compared with vectortransfected control cells. As can be seen in Figure 3a , Ier2 expression substantially and consistently increased the speed of closure of wounded monolayers. Similar to the case with non-transformed fibroblasts, relief from contact inhibition resulted in a nuclear localization of Ier2 at the edge of the monolayer (Figure 3b ).
In transwell motility/invasion assays, 1AS cells transfected with either Ier2 or empty vector were seeded onto Matrigel-coated filters of transwell migration chambers, and migration across the filter in response to a chemotactic gradient was assessed. As shown in Figure 3c , ectopic expression of Ier2 dramatically increased cell invasion and migration across the filter.
Together, these data demonstrate that Ier2 expression can promote tumor cell motility and invasiveness.
Ectopic Ier2 expression promotes metastasis of experimental tumors to regional lymph nodes To determine whether Ier2 expression influences tumor metastasis in vivo, we stably transfected 1AS cells with the Ier2 expression construct (Supplementary Figure 5) . Clones of 1AS cells either ectopically expressing Ier2 or transfected with the empty vector were checked in the motility, proliferation apoptosis, adhesion and invasion assays outlined above to verify that stable Ier2 expression had similar effect on these parameters as in transiently transfected cells. The clones were then injected subcutaneously into syngeneic rats, and tumors were allowed to grow to 5 cm in one dimension. Animals were then killed and autopsied for evidence of metastases.
Ier2 expression had no effect on the growth of primary tumors ( Figure 4a ). However, the size of the axillary lymph nodes ipsilateral and regional to the primary tumor was significantly increased in comparison with the contralateral axillary lymph nodes with all Ier2-expressing independent 1AS clones tested. In contrast, no significant increase in the size of the ipsilateral axillary lymph nodes was observed with any of the independent vectortransfected 1AS clones tested (Figure 4b ). Examination of the enlarged lymph nodes draining Ier2-expressing tumors revealed them to be full of metastatic tumor cells (Figure 4c ). Together, these data suggest that ectopic Ier2 expression is sufficient to stimulate the metastasis of 1AS tumor cells to regional lymph nodes.
Ier2 expression is upregulated in many human tumor types and correlates with poor metastasis-free and overall survival The data above suggest that Ier2 expression can be sufficient to promote metastasis in experimental tumors. To determine whether Ier2 expression is of relevance to human tumors, we used affinity-purified polyclonal antiIer2 antibodies to perform immunohistochemistry on human tumor sections. We found that Ier2 is robustly overexpressed in a number of different types of primary tumors compared with the corresponding non-transformed tissue (Table 1) , including cancers of the pancreas, breast, endometrium, cervix, liver and intestine (Figure 5a ).
To determine whether Ier2 expression is associated with tumor metastasis in human tumors, we performed quantitative reverse transcriptase-PCR analysis using microdissected tumor material obtained from 39 patients with colorectal adenocarcinomas. None of them had metastases at surgery, but 17 developed distant metastases metachronously. Analysis of Ier2 expression in these samples revealed that expression of Ier2 in primary tumors of these patients is a strong predictor of poor prognosis (Figure 5b) . Importantly, Ier2 expression significantly correlates with a short metastasis-free survival (P ¼ 0.0338) and with a poor overall survival (P ¼ 0.0029).
Together, these data indicate that tumor cells can constitutively express Ier2 in a manner that correlates with tumor progression, metastasis and poor prognosis. Ier2 promotes motility and translocates from the cytoplasm to the nucleus upon relief of contact inhibition in 3T3 fibroblasts. Confluent monolayers of 3T3 fibroblasts that had been transfected with either scrambled (Control) or Ier2 siRNA (Ier2 knockdown) were grown in the presence of a silicon insert, and either (a) serum-starved or (b) stimulated with 20% serum. Upon removal of the silicon insert, movement of cells into the resulting cell-free area was monitored microscopically. The reduction in cell-free area was calculated at the indicated time points. The data represent mean and s.e. of three independent experiments. (c) Monolayers of Ier2-inducible 3T3 fibroblasts grown in the presence of a silicon insert were treated with either RSL1 (RSL1) or solvent control (DMSO). Upon removal of the silicon insert, movement of cells into the resulting cell-free area was monitored microscopically and reduction in cell-free area was calculated at the indicated time points. The data represent mean and s.e. of three independent experiments. (d) Confluent monolayers of 3T3 fibroblasts were grown densely under normal culture conditions for 64 h in the presence of a silicon insert. Cells were BrdU pulsed (10 mM) 3 h before fixation. Upon removal of the insert to relieve contact inhibition, cells were immunostained at the indicated time points with the anti-Ier2 antibody 1A2 (green) and anti-BrdU antibodies (red). DAPI staining (blue) was used to visualize nuclei. (Gutmann et al., 2002; Hippo et al., 2002; Yu et al., 2004; French et al., 2005; Skotheim et al., 2005) . Ier2 has also been reported to be induced in gastric epithelial cells in response to Helicobacter infection (Chiou et al., 2001) . Moreover, the Tax protein of the human T-cell leukemia virus type-1 upregulates the expression of Ier2 at the transcriptional level (Chen et al., 2003) . The results we present here extend these observations and demonstrate that Ier2 expression can promote tumor cell motility and metastasis in animal models, is strongly upregulated in a wide variety of human tumors in comparison with the corresponding non-transformed normal tissue and is a predictor of poor metastasis-free and overall survival of patients with colorectal adenocarcinomas. Although little is known about the function of Ier2, its expression has been shown to be induced in a wide range of biological contexts. It is activated upon stimulation of quiescent fibroblasts, T cells and other cell types with serum, 12-O-tetradecanoylphorbol-13-acetate (TPA) or growth factors (Charles et al., 1990; Coleclough et al., 1990; Scott et al., 1994; Fambrough et al., 1999; Keeton et al., 2002) . Ier2 is also associated with apoptosis, as its expression is induced in neurons after N-methyl-Daspartic acid (NMDA) administration in vivo, and in fibroblasts after anisomycin treatment (Chung et al., 2000a (Chung et al., , 2000b . Furthermore, Ier2 is expressed in the ischemic brain, and its ectopic expression induces apoptosis in this context (Schneider et al., 2004) . Ier2 expression also correlates with cell differentiation, for example, during neuronal differentiation of PC12 and H19-7 cells (Charles et al., 1990; Eschelbach et al., 1998; Chung et al., 1998) , and after TPA-induced differentiation of HL-60 cells (Shimizu et al., 1991) . During embryonic development, Ier2 has been reported to determine left-right asymmetry patterning in an fibroblast growth factor (FGF)-dependent manner through interacting with fibp1 (Hong and Dawid, 2009 ).
Ier2 and metastasis
A Neeb et al
Figure 4 Ectopic expression of Ier2 promotes metastasis in vivo.
Groups of eight rats were injected subcutaneously with clones of 1AS cells ectopically expressing Ier2 (P35, P38, P40 and P43) or with control clones transfected with empty vector (V14, V15, V17). Tumor volume was regularly monitored. (a) Animals were killed once their tumors exceeded 50 mm in one dimension. Ier2 expression does not affect the growth of tumors in vivo. The volume of all tumors was compared at the time the first animal needed to be killed. The mean and s.e. for all eight animals in each group is depicted. (b) Development of metastases in the axillary lymph nodes draining the primary tumors. At autopsy, the volume of the axillary lymph nodes ipsilateral (ip) and contralateral (co) to the primary tumor was measured. The contralateral lymph nodes served as a negative control for metastasis formation. The volume of each axillary lymph node is plotted for all eight rats injected with the different 1AS clones. The volume of the ipsilateral and contralateral lymph nodes for each clone was statistically compared using the Mann-Whitney rank test. (c) Representative H and E staining of a section of a paraffin-embedded enlarged ipsilateral lymph node taken from a rat bearing an Ier2-expressing tumor. The staining demonstrates that most of the tissue within the lymph node is composed of metastatic tumor cells.
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The Ier2 protein contains two putative nuclear localization signals (Shimizu et al., 1991) and there is some limited homology to the nuclear proteins JunB and JunD (Coleclough et al., 1990; Scott et al., 1994) . Published evidence to date using nuclear/cytoplasmic fractionation techniques suggests that Ier2 localizes exclusively in the cytoplasm of 3T3 and PC12 cells (Charles et al., 1990) , although at least a partial nuclear localization has also been reported (Chung et al., 2000a; Takaya et al., 2009) . Furthermore, Ier2 can transcriptionally regulate the ISYNA1 promoter (Takaya et al., 2009) . Here, we show that cell density strongly influences subcellular localization of the Ier2 protein.
In particular, release of cells from contact inhibition resulted in a translocation of Ier2 from the cytoplasm to the nucleus. Given recent evidence suggesting a direct role in transcriptional regulation for Ier2 (Takaya et al., 2009) , the regulated compartmentalization of Ier2 is presumably an important means by which the cell regulates the activity of this protein.
Our data indicate that Ier2 expression in 3T3 fibroblasts and 1AS pancreatic tumor cells promotes cell motility. The enhanced motility and invasiveness of 1AS cells we observed upon ectopic Ier2 expression is 
Proximal convoluted tubules weakly positive Distal convoluted tubules strongly positive Mammary carcinoma
Heterogeneous staining of ductal epithelium Heterogeneous staining Hepatic carcinoma
Strong staining of intracalated and intercalated ducts 5/10 ( þ )/ þ Islets of Langerhans weakly positive Prostate carcinoma 4/9 þ þ þ /À weak heterogeneous epithelial staining
Abbreviations: RCC, renal cell carcinoma; SCC, squamous cell carcinoma. Staining of multiple tissue arrays of human tumors with matched normal tissues with anti-Ier2 antibodies. Biocat common cancer arrays MA, MB and MC and matched normal tissue arrays MAN, MBN and MCN were used. Full details of the histopathology of the sections on these multiple tissue arrays can be found on http://www.biocat.de. Staining was graded: À: no staining; þ : weak staining; þ þ : moderate staining; þ þ þ : strong staining.
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A Neeb et al likely to contribute to the induction of metastasis that occurred when cells were injected into experimental animals. However, we also observed that enhanced Ier2 expression does not invariably promote motility. In the case of 3T3 cells, although knockdown of Ier2 reduced motility after relief of contact inhibition, increased Ier2 expression over and above endogenous levels observed in serum-induced post-quiescent fibroblasts did not further enhance motility, suggesting that there may be an upper threshold to Ier2-induced motility. Furthermore, using RSL1-inducible Ier2 expression in non-transformed NMuMG mammary epithelial cells (Wallbaum et al., 2009) , we also did not observe increased motility in response to induction of Ier2 Ier2 and metastasis A Neeb et al expression (data not shown). In 1AS tumor cells, endogenous levels of Ier2 may be lower than the putative upper threshold, explaining why ectopic Ier2 expression was able to increase motility. Consistent with this notion, we observed that expression levels of Ier2 in serum-induced post-quiescent fibroblasts were higher than the constitutive expression in tumor cells (Figure 1b) . Alternatively, an upper threshold may not exist in tumor cells. Either way, these data indicate that the ability of Ier2 to promote motility is likely to be cell context dependent. As outlined above, some studies have shown enhanced Ier2 expression during the induction of apoptosis, and there is some evidence that Ier2 expression may be able to promote apoptosis (Schneider et al., 2004) . However, in the experiments presented here, we found no evidence for apoptosis induction in response to Ier2 expression. Therefore, any role for Ier2 in the induction of apoptosis may be dependent on the levels and kinetics of Ier2 protein expression, as well as on the cellular context.
In summary, the data we present here provide evidence of a role for Ier2 in regulating cell motility. In the context of tumor cells this translates into increased invasiveness and an enhanced ability to form metastases. Accordingly, expression of Ier2 in the primary tumors of colorectal cancer patients correlates with poor prognosis. Future work will focus on understanding the molecular function of Ier2, with a view towards the development of therapeutic strategies that inhibit the positive effects of Ier2 on tumor progression.
Materials and methods

Cells and cell lines
The culture conditions and properties of the tumor cell lines used in this paper have been described previously (Nestl et al., 2001; Mengwasser et al., 2004) . We have previously described 3T3 cells, Ier2-inducible 3T3 cells, their cultivation under dense and sparse conditions, stimulation of Ier2 expression with RSL1 (New England Biolabs, Frankfurt a. M., Germany) and 5-bromo-2 0 -deoxyuridine pulsing and staining used in this paper (Wallbaum et al., 2009) . For serum deprivation experiments, cells were cultivated in medium containing 0.3% serum for 48 h. Fluorescence-activated cell sorting cell-cycle profile analysis and fluorescence immunostaining were performed as described previously (Wallbaum et al., 2009) . The anti-FAK antibody (C903) was purchased from Santa Cruz (Heidelberg, Germany). Freshly isolated splenocytes were incubated with and without concanavilin A (5 mg/ml) for 72 h.
RNA preparation and northern blots
Preparation of polyadenylated RNA and northern blots was performed as described previously (Hofmann et al., 1998) . Blots were probed sequentially at high stringency using a fulllength Ier2 probe and a GAPDH (glyceraldehyde 3-phosphate dehydrogenase) probe. In between each probing, the blots were stripped in 0.1% SDS at 100 1C.
Generation of anti-Ier2 antibodies
To generate a glutathione-S-transferase (GST)-Ier2 fusion protein, a fragment of the Ier2 cDNA (corresponding to amino acids 25-142 of GenBank accession number M59821) was cloned downstream of and in-frame with the GST gene in the pGEX-1 expression vector, and soluble GST-Ier2 fusion protein was produced as described previously (Smith and Johnson, 1988) . Rabbits were immunized with the fusion protein and bleeds were assessed for anti-Ier2 activity in ELISA (enzyme-linked immunosorbent assay) assays. Positive serum was purified using GST-sepharose to remove anti-GST antibodies, followed by affinity purification over GST-Ier2 sepharose. The same fusion protein was used to produce monoclonal antibodies. Immunization of Balb/C mice with the fusion protein and production of hybridomas were performed as described previously (Harlow and Lane, 1998; Niebuhr et al., 1998) . Hybridoma supernatants were differentially screened in ELISA assays for their ability to bind to GSTIer2 but not to the GST protein. One of these monoclonal antibodies (1A2) was found to bind to endogenous mouse and rat Ier2 in a number of immunoassays (Wallbaum et al., 2009 ).
Cloning of a Ier2 expression construct
The entire coding sequence of Ier2 was amplified by reverse transcriptase-PCR and cloned in-frame with the V5 tag in the pcDNA3.1. vector. The inclusion of the C-terminal V5 tag permitted identification of ectopically expressed Ier2 in transfected cells. The following primers were used: 5 0 -GCGGATCCTATGGAAGTACAGAAAGAAGCGCAGC GCATCATGACTGTC-3 0 and 5 0 -CGCAAGCTTGAAGGC CACCACAGCTCGCACC-3 0 . The underlined bases correspond to the initiating methionine codon and the penultimate codon of Ier2. Transfections 1AS cells were stably or transiently transfected with the Ier2 expression construct using Tfx50 (Promega, Mannheim, Germany) or Geneporter 2 (Genlantis, San Diego, CA, USA) according to the manufacturer's instructions. For controls, cells were transfected with the corresponding empty vector as appropriate. Stably transfected cells were selected with 800 mg/ml G418. Selected cells were either pooled or were picked as colonies as indicated in the text. Expression of the transfected expression construct was confirmed by western blotting.
Western blots
Western blots were performed as described previously (Baumann et al., 2005) . Anti-V5 tag antibodies were purchased from Invitrogen, and anti-b-actin and anti-vinculin antibodies were purchased from Sigma-Aldrich (Taufkirchen, Germany).
Migration, adhesion, apoptosis and proliferation assays Monolayer wounding assays, adhesion, proliferation and transwell migration and invasion assays were performed as described previously (Baumann et al., 2005) , except for the Ier2 and metastasis A Neeb et al silicon insert used to create a cell-free area in the monolayer wounding assays described here. Apoptosis assays were performed using the Cell Death Detection ELISA PLUS kit (Roche Diagnostics, Mannheim, Germany) according to the manufacturer's instructions.
Tumor experiments in vivo Syngeneic rats were injected subcutaneously with 1 Â 10 6 cells in phosphate-buffered saline. Animals were monitored until their tumors grew to the German legal limit (50 mm in one dimension), or until they became moribund, at which time they were killed and an autopsy was performed. At autopsy, the size of the primary tumor was measured and the number, size and location of metastases in the draining lymph nodes and other organs were assessed. The lymph nodes and lungs were also analyzed histologically in parallel to determine the presence of metastases. Statistical significance of the results was determined using the Mann-Whitney rank test.
Immunostaining
Sections of paraffin-embedded human tumor samples (Biocat, Heidelberg, Germany) were deparaffinized and blocked for 15 min with 10% goat serum in phosphate-buffered saline. The samples were incubated with 5 mg/ml purified polyclonal antiIer2 antibodies and then for 30 min with biotinylated secondary antibody (Dako, Hamburg, Germany). Antibody staining was detected using StreptABComplex (Dako) according to the manufacturer's instructions and color development with 3-amino-9-ethylcarbazole (AEC). Sections were counterstained with hematoxylin. In other experiments, tissues derived from tumor-bearing rats were paraffin embedded and stained with H and E using standard procedures.
Quantitative reverse transcriptase-PCR Tissue specimens from 39 colon cancer patients were obtained with written consent. All patients were previously untreated, did not have a history of familial colon cancer and underwent surgical resection at the Robert-Ro¨ssle Cancer Hospital (Berlin, Germany). None of them had metastases at the time of surgery, but 17 developed distant metastases metachronously. Tumor specimens (all adenocarcinomas) were snap frozen in liquid nitrogen and blinded for analysis. Tumor cell populations were microdissected from serial cryosections and total RNA was isolated. Reverse transcriptase reactions were performed with 25 ng of total RNA (MuLV Reverse Transcriptase; Perkin-Elmer, Weiterstadt, Germany). Quantitative real-time reverse transcriptase-PCR was carried out as described previously (Stein et al., 2002) . Ier2 expression analysis was performed based on the hybridization probe detection format using amplicon-specific hybridization probes (Roche LightCycler format, Roche Diagnostics). The following primers (synthesized by BioTeZ, Berlin, Germany) and probes (synthesized by TIB MOLBIOL, Berlin, Germany) were used: forward 5 0 -CAGACACACGGACACAATCAG-3 0 , reverse 5 0 -CCGCACGAAAGGTAAACAAAG-3 0 , fluorescein isothiocyanate 5 0 -CCAATCTGGGGAGGGGAACATC-3 0 ; LCRed640 5 0 -TTGCCAGGGAGTTTCTGAGGGTCT-3 0 . PCR was carried out as follows: 30 s 95 1C, then 45 Â (10 s 95 1C, 10 s 60 1C, 10 s 72 1C), melting curve 40-95 1C. For calibration, we used total RNA from the Ier2-expressing human prostate cancer cell line PC-3. The PC-3-derived calibrator cDNA was used in serial dilutions for generating a standard curve in each quantitative PCR run. The Ier2 mRNA expression of each tissue sample was calculated as percentage of the Ier2 mRNA expression of the defined calibrator sample, which was set at 100%. Each sample was run in duplicate, and the mean was used for analysis of the correlation between Ier2 expression and patient survival. Statistical significance of Kaplan-Meier curves was evaluated with the log-rank test.
